Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans.
暂无分享,去创建一个
Masamichi Okubo | N. Kohno | Nobuoki Kohno | Kiminori Yamane | Shuhei Nakanishi | M. Okubo | N. Kamei | S. Nakanishi | K. Yamane | Nozomu Kamei | Nozomu Kamei
[1] N. Sattar,et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. , 2002, Diabetes care.
[2] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[3] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[4] S. Haffner,et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.
[5] W. Ricart,et al. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness , 1999, Diabetologia.
[6] N Rifai,et al. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. , 1999, Clinical chemistry.
[7] N. Kohno,et al. Westernization of lifestyle markedly increases carotid intima-media wall thickness (IMT) in Japanese people. , 2003, Atherosclerosis.
[8] M. Carrier,et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism , 2001, Diabetologia.
[9] M. Yamakido,et al. Westernized food habits and concentrations of serum lipids in the Japanese. , 1993, Atherosclerosis.
[10] L. Kuller,et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. , 2001, Diabetes.
[11] M. Walker,et al. Human Insulin Receptor Substrate‐1: Variant Sequences in Familial Non‐insulin‐dependent Diabetes Mellitus , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[12] K. Kayaba,et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study. , 2001, American journal of epidemiology.
[13] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[14] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[15] M. Hori,et al. C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis , 2001, Circulation.
[16] R. Gibson,et al. Dietary polyunsaturated fatty acids and inflammatory mediator production. , 2000, The American journal of clinical nutrition.
[17] E. Ford. Body mass index, diabetes, and C-reactive protein among U.S. adults. , 1999, Diabetes care.
[18] C. Meisinger,et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. , 2003, Archives of internal medicine.
[19] M. Carrier,et al. Oxidative stress impairs insulin internalization in endothelial cells in vitro , 2001, Diabetologia.
[20] J. Gabrilove,et al. The acute metabolic effects of tumor necrosis factor administration in humans. , 1987, Archives of surgery.
[21] A. Hofman,et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[22] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[23] J. Peña,et al. Enhanced Acute-Phase Response and Oxidative Stress in Older Adults with Type II Diabetes , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[24] D. Bell. Inflammation, insulin resistance, infection, diabetes, and atherosclerosis. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[25] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[26] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[27] N. Sattar,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.
[28] M. Yamakido,et al. Incidence of Non‐insulin‐dependent Diabetes Mellitus and Its Risk Factors in Japanese‐Americans Living in Hawaii and Los Angeles , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[29] R. Giorgino,et al. A family history of Type 2 diabetes is associated with increased plasma levels of C‐reactive protein in non‐smoking healthy adult women , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[30] J V Castell,et al. Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.